lincRNA-p21 inhibits the progression of non-small cell lung cancer via targeting miR-17-5p

Non-small-cell lung cancer (NSCLC) is well established as one of the major subtypes of human lung cancer. NSCLC is characterized by a high incidence rate and poor patient prognosis. Previous studies have identified that long intergenic non-coding RNA (lincRNA) serves a key role in the development of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ao, Xiang, Jiang, Ming, Zhou, Jie, Liang, Hongling, Xia, Haoming, Chen, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312999/
https://www.ncbi.nlm.nih.gov/pubmed/30535441
http://dx.doi.org/10.3892/or.2018.6900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312999/
https://www.ncbi.nlm.nih.gov/pubmed/30535441
http://dx.doi.org/10.3892/or.2018.6900

Ejemplares similares